Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Explore content
    • News
      • The week in cell therapy
      • Spotlights
      • In Focus
      • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
    • eBooks
      • Webinars
      • Podcasts
      • Videos
      • Infographics
      • Partners
      • Events
      • Events news
      • Glossary

    Follow us on social media

  • Our journals
    • Our journals
    • Journal content
    • Journal articles

    Follow us on social media

  • Register
From research to clinical production: scaling iPSC and extracellular vesicle processes 17 days 21 hours 40 mins 59 secs REGISTER NOW

Welcome to RegMedNet

10 JUL 2026 GENE THERAPY
Novel gene therapy harnesses brain’s glymphatic system for targeted delivery
10 JUL 2026 CELL THERAPY
Phase I/II Parkinson’s disease cell therapy trial achieves primary endpoint
9 JUL 2026 CANCER
Cell therapy weekly: investigational AAV-based gene therapy for FSHD completes enrollment
8 JUL 2026 PRECLINICAL RESEARCH
Regenerative Medicine Highlights: April – June 2026
3 JUL 2026 STEM CELLS
Lab-grown retinal cells may hold the potential to restore retinal function
3 JUL 2026 CANCER
Triple-target approach for pediatric brain tumors
1 / 6

Sign up for our RegMedNet weekly news round-up

16 JUN 2026 CELL THERAPY / ARTICLE
Advanced iPSC bioprocessing: process improvements for scalable and quality-focused cell production
18 JUN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Industry updates with Dusko Ilic: May 2026
16 JUN 2026 AWARENESS / ARTICLE
World Sickle Cell Day 2026: current progress and developments

Our Journals Journal Content

Journal Content

19 MAY 2026 Editorial / Regenerative Medicine

Exploring gene therapy for developmental and epileptic encephalopathies (DEEs): possibilities or promises?

29 APR 2026 Research Article / Regenerative Medicine

Factors that influence trust in non-standard stem cell therapies among patients with...

4 MAR 2026 Research Article / Regenerative Medicine

Comparative study of the effects of subcutaneously administered umbilical cord-derived mesenchymal stem...

23 FEB 2026 Review / Regenerative Medicine

Clinical applications of induced pluripotent stem cell-mediated therapies in cancer: progress, challenges,...

1 DEC 2025 Research Article / Regenerative Medicine

Reimbursement routes and past practices for advanced therapy medicinal products in the...

27 NOV 2025 Review / Regenerative Medicine

Three-dimensional bio-printed microtissues: precision medicine approach in primary liver cancer

Featured

6 MAY 2026 IN FOCUS
In Focus: Stem cell therapy
21 APR 2026 REGULATION & POLICY / PODCAST
Harmonizing scientific innovation, patient care and regulation in advanced therapies: a podcast with Patrice Faloye
2 APR 2026 SPOTLIGHT
Spotlight on raw materials and supply chain
19 FEB 2026 GENE THERAPY / PODCAST
Breaking barriers in neurodegenerative disorders with gene therapy: a podcast with Deborah Ojutalayo
10 FEB 2026 TISSUE ENGINEERING OR REPLACEMENTS / PODCAST
Innovating and developing tissue engineering beyond replacement: a podcast with Guillermo Ameer
5 FEB 2026 AWARENESS / PODCAST
Research and progress in sickle cell disease and thalassemia: a podcast with Baba Inusa
28 NOV 2025 SPOTLIGHT
Spotlight on cell therapy sources and clinical applications
15 OCT 2025 IN FOCUS
In Focus: AAV characterization and analysis for gene therapy
25 SEP 2025 IN FOCUS
In Focus: Allogeneic cell therapy
5 AUG 2025 IN FOCUS
In Focus: Supply chain

Must Watch

17 JUN 2026 WEBINARS / WEBINAR
From research to clinical production: scaling iPSC and extracellular vesicle processes with confidence
19 MAR 2026 MSCS / WEBINAR
Bridging gaps in MSC therapy development through strategic partnership
30 JAN 2026 INTERVIEWS / VIDEO
Engineering MSC-derived exosome mimetics for bone regeneration: an interview with Jiabing Fan
28 OCT 2025 CELL THERAPY / WEBINAR
Q&A highlights: Cell manufacturing with GMP ancillary material solutions from BioLegend
12 AUG 2025 CELL THERAPY / WEBINAR
Cell manufacturing with GMP ancillary material solutions from BioLegend
14 MAR 2025 MANUFACTURING & SCALE-UP / WEBINAR
Bridging platforms for enhanced & harmonized bioprocess data collaboration
12 FEB 2025 CELL THERAPY / WEBINAR
From bench to patient care: unlocking iPSC potential through innovative science and strategic partnerships
20 JAN 2025 GENE THERAPY / WEBINAR
USP Standards for plasmid DNA: quality control in cell and gene therapy
Scalable hiPSC production for 3D bioprinting
17 JAN 2025 3D PRINTING / WEBINAR
Four billion cells in four days: a scalable 3D bioprinting success story
raw material quality for cell and gene therapies Regulatory standards in cell and gene therapies Regulatory compliant raw materials
23 SEP 2024 GENE THERAPY / WEBINAR
Decoding raw material quality and regulatory standards in cell and gene therapy

What's Trending?

15 JUN 2026 CELL THERAPY / ARTICLE
eBook: Raw materials and supply chain management in GMP cell and gene therapies
18 JUN 2026 CANCER / ARTICLE
Cell therapy weekly: BLA submission planned for Huntington’s gene therapy AMT-130
26 JUN 2026 CELL THERAPY / ARTICLE
US$7.49 grant awarded to develop off-the-shelf CAR-NKT cell therapy for multiple sclerosis
23 JUN 2026 GENE EDITING / ARTICLE
eBook | Viral and non-viral gene delivery approaches
1 JUL 2026 ASIA AND THE REST OF THE WORLD / ARTICLE
Unlocking the potential of regenerative medicine in Europe: an interview with Tanja Xenia Pedersen
19 JUN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Building a consortium to accelerate stem cell models for drug discovery
  • About
  • Advertising & Sponsorship
  • Expert Panel
  • Permissions & content ownership policy
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

RegMedNet is powered by Taylor & Francis Group

RegMedNet, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 RegMedNet